$YTEN w/ +ve FDA CRSPR-AG announcement end of last week, potential headwinds now become tailwinds; only $19m m/cap w/ $14.5m cash /$MON JV and many new traits avail to partner, this co (and ag-editing) has potential to be one of best sector stories of the year
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.